VRAX

Virax Biolabs Group
VRAX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.44M
EV
$-1.40M
Shares Outstanding
4.34M
Beta
1.62
Industry
Biotechnology

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
1
P/E 2026E
-
P/Revenue 2026E
61.00x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Virax Biolabs Group Limited

gainify
VRAX

Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited, a biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, a...

Sector

Healthcare

Industry

Biotechnology

CEO

Foster, James

Employees

19

IPO Date

2022-07-21

Headquarters

BioCity Glasgow Bo’Ness Road Newhouse, Lanarkshire, Lanarkshire, ML1 5UH, United Kingdom

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.